Literature DB >> 32666729

[Trifocal bone transport by using monolateral rail system in treatment of bone defects caused by post-traumatic tibial osteomyelitis].

Peng Ren1, Chuang Ma1.   

Abstract

OBJECTIVE: To study the effectiveness of trifocal bone transport by using monolateral rail system in the treatment of bone defects caused by post-traumatic tibial osteomyelitis.
METHODS: The clinical data of 28 patients with tibial defects caused by post-traumatic osteomyelitis treated with trifocal bone transport technique by using monolateral rail system between January 2012 and June 2017 were retrospectively analyzed. There were 26 males and 2 females, aged 22-59 years (mean, 41.3 years). The causes of injury included 13 cases of traffic accident injury, 9 cases of falling from height, 4 cases of heavy object injury, and 2 cases of crushing injury. The disease duration was 4.5-17.0 months (mean, 7.1 months). The length of bone defect was 6.5-16.8 cm (mean, 10.3 cm). And the range of soft tissue defect ranged from 3.5 cm×2.0 cm to 18.0 cm×11.0 cm. The bone transporting time, external fixation time, duration of regenerate consolidation, and external fixation index were recorded, and the complications were observed. At last follow-up, the bone and functional results were evaluated according to the criteria given by Association for the Study and Application of the Method of the Ilizarov (ASAMI).
RESULTS: All patients were successfully followed up after removing the external fixator with an average of 35 months (range, 24-65 months). The bone transporting time was 41-136 days (mean, 60.2 days), the external fixation time was 7.5-20.0 months (mean, 13.4 months), the external fixation index was 1.1-1.9 months/cm (mean, 1.4 months/cm), the duration of regenerate consolidation was 6.0-16.5 months (mean, 10.5 months). Pin tract infection occurred in 12 cases, delayed union on docking site was occurred in 9 cases, axial deviation was observed in 2 cases, poor regenerate consolidation was presented in 1 case, and refracture on docking site after fixator removal was occurred in 1 case. There was no recurrence of infection, amputation, vascular and neurologic complications, and osteofascial compartment syndrome. At last follow-up, according to ASAMI criterion, the bone healing results were excellent in 17 cases, good in 7 cases, and fair in 4 cases, with an excellent and good rate of 85.7%; the functional results were excellent in 15 cases, good in 10 cases, and fair in 3 cases, with an excellent and good rate of 89.3%.
CONCLUSION: Trifocal bone transport by using monolateral rail system is an effective method in the treatment of bone defect caused by post-traumatic osteomyelitis which can reduce bone transport time, external fixation time, and complications.

Entities:  

Keywords:  Post-traumatic osteomyelitis; bone defect; monolateral rail system; trifocal bone transport

Mesh:

Year:  2020        PMID: 32666729      PMCID: PMC8180421          DOI: 10.7507/1002-1892.201912034

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  34 in total

1.  The treatment of infected nonunion of the tibia following intramedullary nailing by the Ilizarov method.

Authors:  Panagiotis Megas; Alkis Saridis; Antonis Kouzelis; Alkiviadis Kallivokas; Spyros Mylonas; Minos Tyllianakis
Journal:  Injury       Date:  2010-03       Impact factor: 2.586

2.  Masquelet technique versus Ilizarov bone transport for reconstruction of lower extremity bone defects following posttraumatic osteomyelitis.

Authors:  Kai Tong; Ziyi Zhong; Yulan Peng; Chuangxin Lin; Shenglu Cao; YunPing Yang; Gang Wang
Journal:  Injury       Date:  2017-04-04       Impact factor: 2.586

3.  Ilizarov trifocal lengthening followed by intramedullary nailing for massive posttraumatic tibial bone defects.

Authors:  Naser M Selim
Journal:  Acta Orthop Belg       Date:  2013-12       Impact factor: 0.500

4.  Salvage of infected non-union of the tibia with an Ilizarov ring fixator.

Authors:  Muhammad Shahid Khan; Haroon Rashid; Masood Umer; Irfan Qadir; Kamran Hafeez; Arshad Iqbal
Journal:  J Orthop Surg (Hong Kong)       Date:  2015-04       Impact factor: 1.118

5.  Essential oil obtained from micropropagated lavender, its effect on HSF cells and application in cosmetic emulsion as a natural protective substance.

Authors:  D Andrys; M Adaszyńska-Skwirzyńska; D Kulpa
Journal:  Nat Prod Res       Date:  2017-08-07       Impact factor: 2.861

6.  Ilizarov Treatment Protocols in the Management of Infected Nonunion of the Tibia.

Authors:  Martin McNally; Jamie Ferguson; Raj Kugan; David Stubbs
Journal:  J Orthop Trauma       Date:  2017-10       Impact factor: 2.512

7.  Bone transport for postinfectious segmental tibial bone defects with a combined ilizarov/taylor spatial frame technique.

Authors:  Francesco Sala; Ahmed M Thabet; Fabio Castelli; Anna N Miller; Dario Capitani; Giovanni Lovisetti; Tazio Talamonti; Saurabh Singh
Journal:  J Orthop Trauma       Date:  2011-03       Impact factor: 2.512

8.  The Ilizarov method in the management of giant-cell tumours of the proximal tibia.

Authors:  H Tsuchiya; K Tomita; Y Shinokawa; K Minematsu; S Katsuo; J Taki
Journal:  J Bone Joint Surg Br       Date:  1996-03

9.  Trifocal versus bifocal bone transport in treatment of long segmental tibial bone defects.

Authors:  M A Catagni; W Azzam; F Guerreschi; L Lovisetti; P Poli; M S Khan; L M Di Giacomo
Journal:  Bone Joint J       Date:  2019-02       Impact factor: 5.082

Review 10.  The treatment of infected tibial nonunion by bone transport using the Ilizarov external fixator and a systematic review of infected tibial nonunion treated by Ilizarov methods.

Authors:  P Yin; Q Zhang; Z Mao; T Li; L Zhang; P Tang
Journal:  Acta Orthop Belg       Date:  2014-09       Impact factor: 0.500

View more
  1 in total

1.  Effect of Annular External Fixator-Assisted Bone Transport on Clinical Healing, Pain Stress and Joint Function of Traumatic Massive Bone Defect of Tibia.

Authors:  Xiaoliang Song; Xinzhong Shao
Journal:  Comput Math Methods Med       Date:  2022-07-15       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.